Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lineage Cell Therapeutics (LCTX) Capital Leases: 2014-2024

Historic Capital Leases for Lineage Cell Therapeutics (LCTX) over the last 11 years, with Dec 2024 value amounting to $67,000.

  • Lineage Cell Therapeutics' Capital Leases fell 50.00% to $40,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $40,000, marking a year-over-year decrease of 50.00%. This contributed to the annual value of $67,000 for FY2024, which is 26.37% down from last year.
  • Latest data reveals that Lineage Cell Therapeutics reported Capital Leases of $67,000 as of FY2024, which was down 26.37% from $91,000 recorded in FY2023.
  • In the past 5 years, Lineage Cell Therapeutics' Capital Leases ranged from a high of $91,000 in FY2023 and a low of $26,000 during FY2020.
  • For the 3-year period, Lineage Cell Therapeutics' Capital Leases averaged around $80,667, with its median value being $84,000 (2022).
  • Its Capital Leases has fluctuated over the past 5 years, first plummeted by 66.23% in 2020, then soared by 180.00% in 2022.
  • Yearly analysis of 5 years shows Lineage Cell Therapeutics' Capital Leases stood at $26,000 in 2020, then increased by 15.38% to $30,000 in 2021, then skyrocketed by 180.00% to $84,000 in 2022, then rose by 8.33% to $91,000 in 2023, then dropped by 26.37% to $67,000 in 2024.